空间蛋白质组定型阐明了新辅助化疗免疫疗法在食道状细胞癌中的免疫决定因素
Chao Wu1, Guoqing Zhang1, Lin Wang2
1Department of Medical Oncology, Senior Department of Oncology, Chinese PLA General Hospital, The Fifth Medical Center, Beijing, China.
Oncogene
|August 9, 2024
概括
一种结合PD-1阻断,NAB-PACLITAXEL和S-1的新辅助化疗免疫疗法对食道状细胞癌显示出有前途. 空间蛋白质组分析确定了免疫细胞模式,预测了治疗反应.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 蛋白质组学是指蛋白质组学.
背景情况:
- 食道状细胞癌 (ESCC) 是积极的,预后不佳.
- 新辅助疗法旨在改善手术前的结果.
- 了解瘤微环境 (TME) 对治疗疗效至关重要.
研究的目的:
- 评估新辅助化学免疫疗法 (托里帕利马布,纳布-帕克利塔塞尔,S-1) 对于局部发达的ESCC.
- 将临床数据与TME的空间蛋白质基因分析 (成像质细胞计 - IMC) 整合起来.
- 识别TME特征,预测对治疗的反应和抗性.
主要方法:
- 与60名局部发达ESCC患者进行的II期临床试验.
- 新辅助治疗:托里帕利马布 (PD-1 阻断),纳布-帕克利塔塞尔和S-1.
- 治疗后分析:手术切除,空间蛋白质组定型的IMC,用于预测建模的机器学习 (SVM,RF).
主要成果:
- 62%的患者有重大病理反应 (MPR);29%的患者有病理完整反应 (pCR).
- IMC揭示了空间免疫细胞分布 (CD8+ T细胞,TLS中的B细胞,S100A9+巨细胞) 预测了结果.
- 机器学习模型在基于空间特征的药物反应预测方面实现了97%的AUC.
结论:
- 新辅助化学免疫疗法在局部发达的ESCC中显示出显著的疗效.
- 对TME的空间蛋白质定型提供了对治疗反应机制的关键见解.
- 整合IMC和机器学习可以指导ESCC个性化治疗策略.
相关概念视频
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...